← back to search

Jianfeng Li

Henan Forestry Vocational College · CN
Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Cancer-related molecular mechanisms research, and Bioinformatics and Genomic Networks.
h-index
45
citations
8,579
works
303
NIH funding
primary concept
Medicine
email

Recent publications

Molecular insight into the interplay among heterogeneous plasmacytes and microenvironment cells and their clinical relevance in myeloma.
2026cited by 0position: contributordoi
Targeting ZMIZ1 induces differentiation in acute myeloid leukemia via chromatin remodeling.
2026cited by 0position: contributordoi
HSCs/MPPs as cells of origin with altered differentiation hierarchy impairing immunomicroenvironment in <i>PML::RARA</i> and <i>CBFα/β</i> fusion AML.
2026cited by 0position: contributordoi
A novel nanobody-based TCR-like CAR-T therapy targeting PRAME for the treatment of acute myeloid leukemia.
2026cited by 0position: contributordoi
Targeting RBPMS selectively eliminates FOXO1-mediated stem cell signatures in mouse models of acute myeloid leukemia.
2026cited by 0position: contributordoi
VAM: A Multimodal Dynamical Foundation Model for Characterizing Human Aging Dynamics and Enabling Virtual Aging Perturbation
2026cited by 0position: contributordoi
Indole-3 propionate inhibits NF-κB/NLRP3-mediated osteoclastogenesis and improves bone quality in high-fat-diet induced obese mice
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2025cited by 3position: middledoi
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study.
2025cited by 3position: contributordoi
HemaScope: A Tool for Analyzing Single-cell and Spatial Transcriptomics Data of Hematopoietic Cells.
2025cited by 3position: contributordoi
Indoleamine 2,3-dioxygenase 1 alters the proportions of B cell subpopulations in the microenvironment of acute myeloid leukemia.
2025cited by 2position: contributordoi
ggalign: Bridging the Grammar of Graphics and Biological Multilayered Complexity.
2025cited by 2position: contributordoi
Resolving Leukemia Heterogeneity and Lineage Aberrations with HematoMap.
2025cited by 2position: contributordoi
Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging.
2025cited by 1position: contributordoi
KMT2A alterations in acute myeloid leukemia: a proposed genetic risk model and transplantation outcomes.
2025cited by 0position: contributordoi
ggalign: Bridging the Grammar of Graphics and Biological Multilayered Complexity
2025cited by 0position: contributordoi
Differences in response to immunotherapy drugs including blinatumomab and inotuzumab ozogamicin in B-ALL patients.
2025cited by 0position: contributordoi
Molecular mechanisms of unique therapeutic potential of CUDC-907 for MEF2D fusion-driven BCP-ALL.
2025cited by 0position: contributordoi
Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma.
2024cited by 30position: contributordoi
The landscape of NUP98 rearrangements clinical characteristics and treatment response from 1491 acute leukemia patients.
2024cited by 21position: contributordoi
The impact of age and number of mutations on the size of clonal hematopoiesis.
2024cited by 17position: contributordoi
Aging and comprehensive molecular profiling in acute myeloid leukemia.
2024cited by 16position: contributordoi
Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny
Communications Biology 2024cited by 13position: middledoi
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy.
2024cited by 9position: contributordoi
Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny.
2024cited by 7position: contributordoi
<i>PICALM::MLLT10</i> may indicate a new subgroup of acute leukemias with miscellaneous immunophenotype and poor initial treatment response but showing sensitivity to venetoclax.
2024cited by 5position: contributordoi
Refined risk stratification helps guiding transplantation choice in adult BCR::ABL1-positive acute lymphoblastic leukemia.
2024cited by 5position: contributordoi
Correlation of serum cotinine with fatty liver index in adults: data from the NHANES March 2017 and 2018
BMC Gastroenterology 2024cited by 4position: middledoi
CSF3R P733T is a deleterious germline variant in acute leukaemia showing gain-of-function-like T618I mutation.
2024cited by 3position: contributordoi
NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia.
2024cited by 2position: contributordoi
GENETIC INSIGHTS INTO SEPSIS: MENDELIAN RANDOMIZATION ANALYSIS OF CEREBROSPINAL FLUID METABOLITES
Shock 2024cited by 1position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 22 papers (2022–2026)Sai‐Juan Chen · Ruijin Hospital11 papers (2022–2026) · 10 papers (2022–2026)Zhu Chen · Shanghai Jiao Tong University7 papers (2022–2026)Yuting Dai · Farmland Irrigation Research Institute5 papers (2022–2026)Xiao-Jian Sun · Shanghai Institute of Hematology5 papers (2022–2026)Shixiang Wang · Central South University5 papers (2022–2025)Jinyan Huang · Guangxi Medical University5 papers (2020–2025) · 5 papers (2024–2026)Hai Fang · Massachusetts Institute of Technology5 papers (2024–2026) · 4 papers (2024–2026)Robert W. Sobol · Brown University4 papers (2013–2023)Wu Wen · Nanchang University4 papers (2020–2022)Renhua Wan · Nanchang University4 papers (2020–2022)Renfeng Shan · Nanchang University4 papers (2020–2022)Shengyue Wang · Shanghai Institute of Hematology4 papers (2024–2026)Haitao Wang · The University of Texas MD Anderson Cancer Center4 papers (2021–2024)Depei Wu · Zhejiang Chinese Medical University3 papers (2022–2024) · 3 papers (2022–2024)Jian-Qing Mi · Elsevier, Inc.3 papers (2024–2026)